本文關(guān)鍵詞： 慢性阻塞性肺疾病 疾病嚴(yán)重程度 肺活量 長(zhǎng)效型吸入劑 醫(yī)療利用　出處：《泰山醫(yī)學(xué)院》2014年碩士論文　論文類型：學(xué)位論文

【摘要】：目的慢性阻塞性肺疾病為重要的呼吸系統(tǒng)疾病,由于其發(fā)病率高、死亡率高、醫(yī)療耗費(fèi)高等特點(diǎn),現(xiàn)已成為一個(gè)重要的公共衛(wèi)生問(wèn)題。長(zhǎng)效型吸入劑為目前COPD的主流治療。本研究旨在評(píng)估長(zhǎng)效型吸入劑在慢性阻塞性肺疾病中的治療效果,從而為優(yōu)化慢性阻塞性肺疾病患者的的治療策略提供資料。方法收集2012年09月至2013年08月的慢性阻塞性肺疾病門診病人(排除哮喘患者和死亡病人)作為研究對(duì)象,比較接受長(zhǎng)效型吸入劑治療者與口服藥物治療者疾病嚴(yán)重程度(輕度、中度、重度、極重度)、肺活量(FEV1,用力呼氣一秒量)的差異,以及對(duì)醫(yī)療利用(累積住院日數(shù)、急診次數(shù)、急性發(fā)作)的影響。對(duì)醫(yī)療利用累積住院日數(shù)、急診次數(shù)、急性發(fā)作的影響。數(shù)據(jù)統(tǒng)計(jì)部分采用SPSS 12.0版軟件,以描述性、推論性分析及強(qiáng)迫進(jìn)入復(fù)回歸分析預(yù)測(cè)變項(xiàng)進(jìn)行分析。結(jié)果研究結(jié)果顯示,使用吸入劑病人中在用藥前后肺功能的差異優(yōu)于使用口服藥病人。在使用口服藥控制COPD的個(gè)案中,其疾病嚴(yán)重程度為極重度個(gè)案中會(huì)影響累積住院日數(shù)情況;故,其功能較差者日常生活活動(dòng)受限,其住院天數(shù)就愈多。長(zhǎng)效型吸入劑,對(duì)于COPD的控制、治療而對(duì)住院天數(shù)、急診次數(shù)使用次數(shù)、急性發(fā)作次數(shù)正面意義。結(jié)論使用長(zhǎng)效型吸入劑病人,可以提高肺功能指標(biāo),對(duì)于COPD疾病的控制是有利的,并可以有效提高病人生活質(zhì)量。有效的疾病管理會(huì)降低COPD病人再住院率,并提升醫(yī)療質(zhì)量,以獲得更大臨床效果。
[Abstract]:Objective chronic obstructive pulmonary disease is an important respiratory disease, because of its high incidence, high mortality, high medical costs and other characteristics. It has become an important public health problem. Long-acting inhalants are the mainstream treatment of COPD. This study was designed to evaluate the efficacy of long-acting inhalants in chronic obstructive pulmonary disease (COPD). Methods from September 2012 to August 2013, patients with chronic obstructive pulmonary disease (COPD) from September 2012 to August 2013 were collected. Exclude asthmatic patients and dead patients) as subjects of the study. The severity of disease (mild, moderate, severe, very severe, vital capacity, FEV1, 1 second forced expiratory volume) was compared between the patients treated with long-acting inhalants and those treated with oral medication. And the effect on medical utilization (cumulative hospitalization days, emergency times, acute seizures). The effect of acute attack. The data were analyzed by SPSS 12.0 software to predict variables by descriptive, inferential and forced multiple regression analysis. The difference of lung function between patients with inhalant and before and after administration was better than that with oral administration. The severity of the disease is extremely severe, which will affect the cumulative number of hospital days; Therefore, its function poor people's daily life activity is limited, its hospitalization days are more. The long-acting inhaler, for COPD control, treatment and hospitalization days, emergency use times. Conclusion the use of long-term inhalant can improve the pulmonary function index and is beneficial to the control of COPD disease. Effective disease management can reduce the rehospitalization rate of COPD patients and improve the quality of medical treatment so as to obtain greater clinical effect.
【學(xué)位授予單位】：泰山醫(yī)學(xué)院
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2014
【分類號(hào)】：R563.9

【參考文獻(xiàn)】

相關(guān)期刊論文 前1條

1 陳明勇;陳斌;劉小英;徐維國(guó);朱靜;;吸入沙美特羅/替卡松粉劑對(duì)穩(wěn)定期COPD患者血清visfatin濃度的影響[J];西部醫(yī)學(xué);2014年02期

，

本文編號(hào)：1452986